Results 1 to 10 of about 373,254 (62)

Dodecyl Creatine Ester Improves Cognitive Function and Identifies Key Protein Drivers Including KIF1A and PLCB1 in a Mouse Model of Creatine Transporter Deficiency [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2023
Creatine transporter deficiency (CTD), a leading cause of intellectual disability is a result of the mutation in the gene encoding the creatine transporter SLC6A8, which prevents creatine uptake into the brain, causing mental retardation, expressive ...
Léa Broca-Brisson   +2 more
exaly   +9 more sources

Epigenetic Alterations in Creatine Transporter Deficiency: A New Marker for Dodecyl Creatine Ester Therapeutic Efficacy Monitoring [PDF]

open access: yesFrontiers in Neuroscience
Creatine transporter deficiency (CTD) is an X-linked disease caused by mutations in the Slc6a8 gene. The impaired creatine uptake in the brain leads to developmental delays with intellectual disability.
Aloise Mabondzo, Léa Broca-Brisson
exaly   +6 more sources

Intranasal Delivery of Dodecyl Creatine Ester Alleviates Motor Deficits and Increases Dopamine Levels in a 6-OHDA Rat Model of Parkinsonism

open access: yesFrontiers in Aging Neuroscience
IntroductionCreatine has been recognized not only as an energy buffer but also for its antioxidant, antiapoptotic, and anti-excitotoxic properties, making it of interest as a neuroprotective agent. Oral creatine monohydrate supplementation is ineffective
Aloise Mabondzo   +2 more
exaly   +6 more sources

Impaired Brain Glucose Metabolism as a Biomarker for Evaluation of Dodecyl Creatine Ester in Creatine Transporter Deficiency: Insights From Patient Brain-Derived Organoids and in Vivo [18F]FDG PET Imaging in a Mouse Model

open access: yesNeurobiology of Disease
Creatine transporter deficiency (CTD) is an inborn error of creatine (Cr) metabolism in which Cr is not properly distributed to the brain due to a mutation in the Cr transporter (CrT) SLC6A8 gene.
Léa Broca-Brisson   +2 more
exaly   +6 more sources

New Insights Into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders

open access: yesPharmaceutics
Brain disorders remain a major global health challenge, highlighting the urgent need for innovative therapeutic strategies and efficient drug-delivery approaches.
Henri Bénech
exaly   +6 more sources

Dodecyl Creatine Ester-Loaded Nanoemulsion as a Promising Therapy for Creatine Transporter Deficiency [PDF]

open access: yesNanomedicine, 2019
Creatine transporter (CrT) deficiency is an X-linked intellectual disability caused by mutations of CrT. Aim: This work focus on the preclinical development of a new therapeutic approach based on a microemulsion (ME) as drug delivery system for dodecyl creatine ester (DCE). Materials & methods: DCE-ME was prepared by titration method.
Alain Pruvost   +2 more
exaly   +7 more sources
Some of the next articles are maybe not open access.

Synthesis and Biological Evaluation of New Creatine Fatty Esters Revealed Dodecyl Creatine Ester as a Promising Drug Candidate for the Treatment of the Creatine Transporter Deficiency

Journal of Medicinal Chemistry, 2013
The creatine transporter deficiency is a neurological disease caused by impairment of the creatine transporter SLC6A8, resulting in mental retardation associated with a complete absence of creatine within the brain and cellular energy perturbation of neuronal cells.
Frédéric Taran   +2 more
exaly   +3 more sources

Dodecyl Creatine Ester and Lipid Nanocapsule: A Double Strategy for the Treatment of Creatine Transporter Deficiency

Nanomedicine, 2015
Catherine Passirani   +2 more
exaly  

pH-Dependent Stability of Creatine Ethyl Ester: Relevance to Oral Absorption

Journal of Dietary Supplements, 2013
Jonathan L. Vennerstrom   +2 more
exaly  

Non-Enzymatic Hydrolysis of Creatine Ethyl Ester

Biochemical and Biophysical Research Communications, 2009
Gordon H Purser
exaly  

Home - About - Disclaimer - Privacy